GRAZAX
Dead · Cancelled DEAD/REGISTRATION/Cancelled/Invalidated
What this record means
The record shows that the mark “GRAZAX” is no longer live; it was cancelled on September 28 2021 because the corresponding international registration was cancelled. The owner listed is ALK‑Abelló A/S, a corporation organized in Denmark. The mark covered pharmaceutical preparations for immunotherapy and allergy treatment, as well as medical and beauty services related to immunotherapy and allergy care, including website‑based patient support and information for medical professionals. A similar name used in these specific pharmaceutical or medical service contexts would raise the closest concern. The record does not give the owner control over every use of the word “GRAZAX” outside these goods and services. No enforcement activity such as oppositions or court actions appears in the supplied history. The latest meaningful event was the cancellation notification in April 2022. For someone considering a similar name, the cancelled status reduces the risk, but the specific pharmaceutical and medical service classes remain a potential point of concern.
Informational only - not legal advice.Mark Trademark, Service Mark
| Drawing type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S) /NUMBER(S) |
| Filing basis | Madrid Protocol (§66(a)). |
| Status | U.S. registration cancelled because International Registration cancelled in whole or in part. |
Key dates
| Application filed | Sep 28, 2011 |
| Published for opposition | May 01, 2012 |
| Registered (Principal) | Jul 17, 2012 |
| Status date | Sep 28, 2021 |
Goods & services
Pharmaceutical preparations, namely, preparations for immunotherapeutic purposes and preparations for diagnosis, prevention and treatment of allergies, allergic rhinitis and asthma, including allergic asthma
Medical services and medical consulting services, including counselling and information regarding immunotherapy, allergy, allergic asthma, allergic rhinitis and asthma; providing patient support relating to immunotherapy as well as to prevention and treatment of allergy, allergic asthma, allergic rhinitis and asthma through a website; providing information to medical professionals relating to immunotherapy as well as prevention and treatment of allergy, allergic asthma, allergic rhinitis and asthma through a website
Madrid Protocol · §66(a)
| Intl. registration no. | 1102120 |
| Intl. registration date | Sep 28, 2011 |
| Intl. renewal date | Sep 28, 2021 |
| Date of automatic protection | May 15, 2014 |
| Notification of designation | Jan 05, 2012 |
| First refusal flag | Yes |
Owner & representation
| Owner | ALK-Abelló A/S |
| Address | Bøge Allé 6-8, DK-2970 Hørsholm, DENMARK |
| Entity | CORPORATION - organized in DENMARK |
| Attorney of record | B. Brett Heavner |
| Correspondent | B. Brett Heavner |
| Attorney email | d********@*****.com |
| Correspondent email | d********@*****.com |
| Correspondent phone | 2********0 |
| Correspondent address | Washington, DISTRICT |